KRISTINA MARCHAND: Open Payments
NPI 1528080322 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$422 in 10 payments from 3 companies in 2025. Trend: 2023 $369 · 2024 $270 · 2025 $422
Food & beverage: $422
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 8 | $383 |
| Organon LLC | 1 | $22 |
| Boston Scientific Corporation | 1 | $17 |
Products named: GEMTESA, NEXPLANON, Axonics.
Industry payments across LA — which companies pay providers there.
